31 reports of this reaction
2.0% of all PANTHENOL reports
#4 most reported adverse reaction
DYSPNOEA is the #4 most commonly reported adverse reaction for PANTHENOL, manufactured by LAON COMMERCE co ltd. There are 31 FDA adverse event reports linking PANTHENOL to DYSPNOEA. This represents approximately 2.0% of all 1,581 adverse event reports for this drug.
Patients taking PANTHENOL who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for PANTHENOL, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for PANTHENOL:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 31 FDA reports for PANTHENOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 2.0% of all adverse event reports for PANTHENOL, making it a notable side effect.
If you experience dyspnoea while taking PANTHENOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.